108 related articles for article (PubMed ID: 10362532)
41. Involvement of template-activating factor I/SET in transcription of adenovirus early genes as a positive-acting factor.
Haruki H; Okuwaki M; Miyagishi M; Taira K; Nagata K
J Virol; 2006 Jan; 80(2):794-801. PubMed ID: 16378981
[TBL] [Abstract][Full Text] [Related]
42. Characterization of a unique aspartate-rich protein of the SET/TAF-family in the human malaria parasite, Plasmodium falciparum, which inhibits protein phosphatase 2A.
Dobson S; Kumar R; Bracchi-Ricard V; Freeman S; Al-Murrani SW; Johnson C; Damuni Z; Chakrabarti D; Barik S
Mol Biochem Parasitol; 2003 Feb; 126(2):239-50. PubMed ID: 12615323
[TBL] [Abstract][Full Text] [Related]
43. Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis.
Nagata K; Kawase H; Handa H; Yano K; Yamasaki M; Ishimi Y; Okuda A; Kikuchi A; Matsumoto K
Proc Natl Acad Sci U S A; 1995 May; 92(10):4279-83. PubMed ID: 7753797
[TBL] [Abstract][Full Text] [Related]
44. Anp32e (Cpd1) and related protein phosphatase 2 inhibitors.
Santa-Coloma TA
Cerebellum; 2003; 2(4):310-20. PubMed ID: 14964690
[TBL] [Abstract][Full Text] [Related]
45. [Separation of fractions of phosphoprotein phosphatase and its protein inhibitors by isoelectrofocusing].
Parsadanian GK; Ter-Tatevosian LP; Sherstnev KB
Biokhimiia; 1981 Jul; 46(7):1236-41. PubMed ID: 6268195
[TBL] [Abstract][Full Text] [Related]
46. Stimulation of DNA transcription by the replication factor from the adenovirus genome in a chromatin-like structure.
Matsumoto K; Okuwaki M; Kawase H; Handa H; Hanaoka F; Nagata K
J Biol Chem; 1995 Apr; 270(16):9645-50. PubMed ID: 7721897
[TBL] [Abstract][Full Text] [Related]
47. Anti-phosphatases take the stage.
Hunter T
Nat Genet; 1998 Apr; 18(4):303-5. PubMed ID: 9537407
[No Abstract] [Full Text] [Related]
48. Inhibition of the PP2A activity by the histone chaperone ANP32B is long-range allosterically regulated by respiratory cytochrome c.
Rivero-Rodríguez F; Díaz-Quintana A; Velázquez-Cruz A; González-Arzola K; Gavilan MP; Velázquez-Campoy A; Ríos RM; De la Rosa MA; Díaz-Moreno I
Redox Biol; 2021 Jul; 43():101967. PubMed ID: 33882408
[TBL] [Abstract][Full Text] [Related]
49. Phosphorylation-mediated control of chromatin organization and transcriptional activity of the tissue-specific osteocalcin gene.
Montecino M; van Wijnen AJ; Lian JB; Stein JL; Stein GS
J Cell Biochem; 1999 Mar; 72(4):586-94. PubMed ID: 10022617
[TBL] [Abstract][Full Text] [Related]
50. TAF-Iβ deficiency inhibits proliferation and promotes apoptosis by rescuing PP2A and inhibiting the AKT/GSK-3β pathway in leukemic cells.
Liu Y; Jia Y; Fu X; He P
Exp Ther Med; 2019 Nov; 18(5):3801-3808. PubMed ID: 31611934
[TBL] [Abstract][Full Text] [Related]
51. Human TAF-Iα promotes oncogenic transformation via enhancement of cell proliferation and suppression of apoptosis.
Nenasheva VV; Makarova IV; Stepanenko EA; Antonov SA; Novosadova EV; Narsullaeva AR; Kozikova LV; Polteva EA; Sleptsova LA; Shcherbatova NA; Khaidarova NV; Andreeva LE; Tarantul VZ
In Vitro Cell Dev Biol Anim; 2021 May; 57(5):531-538. PubMed ID: 34021475
[TBL] [Abstract][Full Text] [Related]
52.
Roth BM; DePalma RM; Cook ME; Varney KM; Weber DJ; Ogretmen B
Biomol NMR Assign; 2021 Oct; 15(2):383-387. PubMed ID: 34156643
[TBL] [Abstract][Full Text] [Related]
53. A Method for Visualization of Incoming Adenovirus Chromatin Complexes in Fixed and Living Cells.
Komatsu T; Dacheux D; Kreppel F; Nagata K; Wodrich H
PLoS One; 2015; 10(9):e0137102. PubMed ID: 26332038
[TBL] [Abstract][Full Text] [Related]
54. Cracking the ANP32 whips: important functions, unequal requirement, and hints at disease implications.
Reilly PT; Yu Y; Hamiche A; Wang L
Bioessays; 2014 Nov; 36(11):1062-71. PubMed ID: 25156960
[TBL] [Abstract][Full Text] [Related]
55. PP2A inhibitors, harzianic acid and related compounds produced by fungus strain F-1531.
Kawada M; Yoshimoto Y; Kumagai H; Someno T; Momose I; Kawamura N; Isshiki K; Ikeda D
J Antibiot (Tokyo); 2004 Mar; 57(3):235-7. PubMed ID: 15152810
[No Abstract] [Full Text] [Related]
56. PP2A complex disruptor SET prompts widespread hypertranscription of growth-essential genes in the pancreatic cancer cells.
Xu H; Wu D; Xiao M; Lei Y; Lei Y; Yu X; Shi S
Sci Adv; 2024 Jan; 10(4):eadk6633. PubMed ID: 38277454
[TBL] [Abstract][Full Text] [Related]
57. Putting a Novel Emphysema Treatment on the SMAP.
Xing D; Wells JM
Am J Respir Cell Mol Biol; 2023 Nov; 69(5):491-492. PubMed ID: 37552790
[No Abstract] [Full Text] [Related]
58. Thirty years of SET/TAF1β/I2PP2A: from the identification of the biological functions to its implications in cancer and Alzheimer's disease.
Di Mambro A; Esposito MT
Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36345878
[TBL] [Abstract][Full Text] [Related]
59. PP2A is activated by cytochrome
Casado-Combreras MÁ; Rivero-Rodríguez F; Elena-Real CA; Molodenskiy D; Díaz-Quintana A; Martinho M; Gerbaud G; González-Arzola K; Velázquez-Campoy A; Svergun D; Belle V; De la Rosa MA; Díaz-Moreno I
Comput Struct Biotechnol J; 2022; 20():3695-3707. PubMed ID: 35891793
[TBL] [Abstract][Full Text] [Related]
60. The E3 Ligase TRIM4 Facilitates SET Ubiquitin-Mediated Degradation to Enhance ER-α Action in Breast Cancer.
Han D; Wang L; Long L; Su P; Luo D; Zhang H; Li Z; Chen B; Zhao W; Zhang N; Wang X; Liang Y; Li Y; Hu G; Yang Q
Adv Sci (Weinh); 2022 Sep; 9(25):e2201701. PubMed ID: 35843886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
